Sarcopenia as a public health problem

[en] The importance of a health problem is based on its current and expected prevalence, its clinical and economic consequences, the social status of people affected by the problem and the availability of an effective treatment. In this paper, we review the main current literature on sarcopenia in order to assess whether this geriatric syndrome could be considered as a major public health problem. Our review highlights that based on its prevalence, its clinical consequences, the limitations of the current available treatments as well as on the fact that many frail patients are affected by this geriatric syndrome, sarcopenia should be considered as a health priority by all interested parties in order to reduce its burden.

Disciplines :

General & internal medicine
Public health, health care sciences & services

Author, co-author :

Bruyère, Olivier ; Université de Liège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé

Beaudart, Charlotte ; Université de Liège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé

Locquet, Médéa ; Université de Liège > Département des sciences de la santé publique > Epidémiologie clinique

Buckinx, Fanny ; Université de Liège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé

PETERMANS, Jean ; Centre Hospitalier Universitaire de Liège - CHU > Gériatrie

Reginster, Jean-Yves ; Université de Liège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé

Language :

English

Title :

Sarcopenia as a public health problem

Publication date :

2016

Journal title :

European Geriatric Medicine

ISSN :

1878-7649

eISSN :

1878-7657

Publisher :

Elsevier

Volume :

Issue :

Pages :

272-5

Peer reviewed :

Peer reviewed

Available on ORBi :

since 03 February 2016

Statistics

Number of views

119 (29 by ULiège)

Number of downloads

9 (9 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Morley JE, Anker SD, von Haehling S. Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology-update 2014. J Cachexia Sarcopenia Muscle 2014;5(4):253-9. http://dx.doi.org/10.1007/s13539-014-0161-y.
Rosenberg IH. Summary comments. Am J Clin Nutr 1989;50(5):1231-3.
Cooper C, Dere W, Evans W, Kanis JA, Rizzoli R, Sayer AA, et al. Frailty and sarcopenia: definitions and outcome parameters. Osteoporos Int 2012;23(7):1839-48. http://dx.doi.org/10.1007/s00198-012-1913-1.
Wang C, Bai L. Sarcopenia in the elderly: basic and clinical issues. Geriatr Gerontol Int 2012;12(3):388-96. http://dx.doi.org/10.1111/j.1447-0594. 2012.00851.x.
Cruz-Jentoft AJ, Landi F, Schneider SM, Zuniga C, Arai H, Boirie Y, et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International sarcopenia initiative (EWGSOP and IWGS). Age Ageing 2014;43(6):748-59. http://dx.doi.org/10.1093/ageing/afu115.
Beaudart C, Reginster JY, Slomian J, Buckinx F, Locquet M, Bruyere O. Preva-lence of sarcopenia: the impact of different diagnostic cut-off limits. J Mus-culoskelet Neuronal Interact 2014;14(4):425-31.
Beaudart C, Reginster JY, Slomian J, Buckinx F, Dardenne N, Quabron A, et al. Estimation of sarcopenia prevalence using various assessment tools. Exp Gerontol 2015;61:31-7. http://dx.doi.org/10.1016/j.exger.2014.11.014.
Pagotto V, Silveira EA. Methods, diagnostic criteria, cutoff points, and preva-lence of sarcopenia among older people. Sci World J 2014;2014:231312. http://dx.doi.org/10.1155/2014/231312.
Janssen I, Shepard DS, Katzmarzyk PT, Roubenoff R. The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc 2004;52(1):80-5.
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on sarcopenia in older people. Age Ageing 2010;39(4):412-23. http://dx.doi.org/10.1093/ageing/afq034.
Edwards MH, Dennison EM, Aihie Sayer A, Fielding R, Cooper C. Osteoporosis and sarcopenia in older age. Bone 2015. http://dx.doi.org/10.1016/j.bone. 2015.04.016.
Kalyani RR, Corriere M, Ferrucci L. Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. Lancet Diabetes Endocrinol 2014;2(10):819-29. http://dx.doi.org/10.1016/S2213-8587(14) 70034-8.
Cesari M, Rolland Y, Abellan Van Kan G, Bandinelli S, Vellas B, Ferrucci L. Sarcopenia-related parameters and incident disability in older persons: results from the "invecchiare in Chianti" study. J Gerontol A Biol Sci Med Sci 2015;70(4):457-63. http://dx.doi.org/10.1093/gerona/glu181.
Landi F, Liperoti R, Russo A, Giovannini S, Tosato M, Capoluongo E, et al. Sarcopenia as a risk factor for falls in elderly individuals: results from the ilSIRENTE study. Clin Nutr 2012;31(5):652-8. http://dx.doi.org/10.1016/j.clnu.2012.02.007.
Moreland JD, Richardson JA, Goldsmith CH, Clase CM. Muscle weakness and falls in older adults: a systematic review and meta-analysis. J Am Geriatr Soc 2004;52(7):1121-9. http://dx.doi.org/10.1111/j.1532-5415.2004.52310.x.
Landi F, Russo A, Liperoti R, Pahor M, Tosato M, Capoluongo E, et al. Midarm muscle circumference, physical performance and mortality: results from the aging and longevity study in the Sirente geographic area (ilSIRENTE study). Clin Nutr 2010;29(4):441-7. http://dx.doi.org/10.1016/j.clnu.2009.12.006.
Rantanen T. Muscle strength, disability and mortality. Scand J Med Sci Sports 2003;13(1):3-8.
Cooper R, Kuh D, Hardy R, Mortality review G, Falcon. Teams HAS. Objectively measured physical capability levels and mortality: systematic review and meta-analysis. BMJ 2010;341:c4467. http://dx.doi.org/10.1136/bmj.c4467.
Landi F, Cruz-Jentoft AJ, Liperoti R, Russo A, Giovannini S, Tosato M, et al. Sarcopenia and mortality risk in frail older persons aged 80 years and older: results from ilSIRENTE study. Age Ageing 2013;42(2):203-9. http://dx.doi.org/10.1093/ageing/afs194.
Arango-Lopera VE, Arroyo P, Gutierrez-Robledo LM, Perez-Zepeda MU, Cesari M. Mortality as an adverse outcome of sarcopenia. J Nutr Health Aging 2013;17(3):259-62. http://dx.doi.org/10.1007/s12603-012-0434-0.
Alexandre Tda S, Duarte YA, Santos JL, Wong R, Lebrao ML. Sarcopenia according to the European Working Group on sarcopenia in older people (EWGSOP) versus dynapenia as a risk factor for mortality in the elderly. J Nutr Health Aging 2014;18(8):751-6. http://dx.doi.org/10.1007/s12603-014-0450-3.
Woo J, Leung J, Morley JE. Defining sarcopenia in terms of incident adverse outcomes. J Am Med Dir Assoc 2015;16(3):247-52. http://dx.doi.org/10.1016/j.jamda.2014.11.013.
Bischoff-Ferrari HA, Orav JE, Kanis JA, Rizzoli R, Schlogl M, Staehelin HB, et al. Comparative performance of current definitions of sarcopenia against the prospective incidence of falls among community-dwelling seniors age 65 and older. Osteoporos Int 2015. http://dx.doi.org/10.1007/s00198-015-3194-y.
Shiozu H, Higashijima M, Koga T. Association of sarcopenia with swallowing problems, related to nutrition and activities of daily living of elderly individuals. J Phys Ther Sci 2015;27(2):393-6. http://dx.doi.org/10.1589/jpts.27.393.
Beaudart C, Reginster JY, Petermans J, Gillain S, Quabron A, Locquet M, et al. Quality of life and physical components linked to sarcopenia: the SarcoPhAge study. Exp Gerontol 2015;69:103-10. http://dx.doi.org/10.1016/j.exger. 2015.05.003.
Patel HP, Syddall HE, Jameson K, Robinson S, Denison H, Roberts HC, et al. Prevalence of sarcopenia in community-dwelling older people in the UK using the European Working Group on Sarcopenia in older people (EWGSOP) definition: findings from the Hertfordshire Cohort Study (HCS). Age Ageing 2013;42(3):378-84. http://dx.doi.org/10.1093/ageing/afs197.
Silva Neto LS, Karnikowiski MGO, Tavares AB, Lima RM. Associação entre sarcopenia, obesidade sarcopênica e força muscular com variáveis relaciona-das de qualidade de vida em idosas. Braz J Phys Ther 2012;16:360-7.
Rizzoli R, Reginster JY, Arnal JF, Bautmans I, Beaudart C, Bischoff-Ferrari H, et al. Quality of life in sarcopenia and frailty. Calcif Tissue Int 2013;93(2):101-20. http://dx.doi.org/10.1007/s00223-013-9758-y.
Beaudart C, Biver E, Reginster JY, Rizzoli R, Rolland Y, Bautmans I, et al. Development of a self-administrated quality of life questionnaire for sarco-penia in elderly 65 years and older: the SarQoL. Age Ageing 2015 [In press].
Sousa AS, Guerra RS, Fonseca I, Pichel F, Amaral TF. Sarcopenia among hospitalized patients - A cross-sectional study. Clin Nutr doi:http://dx.doi.org/10.1016/j.clnu.2014.12.015.
Martinez BP, Batista AK, Gomes IB, Olivieri FM, Camelier FW, Camelier AA. Frequency of sarcopenia and associated factors among hospitalized elderly patients. BMC Musculoskelet Disord 2015;16:108. http://dx.doi.org/10.1186/s12891-015-0570-x.
Cerri AP, Bellelli G, Mazzone A, Pittella F, Landi F, Zambon A, et al. Sarcopenia and malnutrition in acutely ill hospitalized elderly: prevalence and outcomes. Clin Nutr 2015;34(4):745-51. http://dx.doi.org/10.1016/j.clnu.2014.08.015.
Di Monaco M, Castiglioni C, Vallero F, Di Monaco R, Tappero R. Sarcopenia is more prevalent in men than in women after hip fracture: a cross-sectional study of 591 inpatients. Arch Gerontol Geriatr 2012;55(2):e48-52. http://dx.doi.org/10.1016/j.archger.2012.05.002.
Park S, Ham JO, Lee BK. A positive association between stroke risk and sarcopenia in men aged ≥ 50 years, but not women: results from the Korean National Health and Nutrition Examination Survey 2008-2010. J Nutr Health Aging 2014;18(9):806-12. http://dx.doi.org/10.1007/s12603-014-0516-2.
Ozola Zalite I, Zykus R, Francisco Gonzalez M, Saygili F, Pukitis A, Gaujoux S, et al. Influence of cachexia and sarcopenia on survival in pancreatic ductal adenocarcinoma: a systematic review. Pancreatology 2015;15(1):19-24. http://dx.doi.org/10.1016/j.pan.2014.11.006.
Rozenberg D, Wickerson L, Singer LG, Mathur S. Sarcopenia in lung transplan-tation: a systematic review. J Heart Lung Transplant 2014;33(12):1203-12. http://dx.doi.org/10.1016/j.healun.2014.06.003.
Friedman J, Lussiez A, Sullivan J, Wang S, Englesbe M. Implications of sarco-penia in major surgery. Nutr Clin Pract 2015;30(2):175-9. http://dx.doi.org/10.1177/0884533615569888.
Sayer AA, Robinson SM, Patel HP, Shavlakadze T, Cooper C, Grounds MD. New horizons in the pathogenesis, diagnosis and management of sarcopenia. Age Ageing 2013;42(2):145-50. http://dx.doi.org/10.1093/ageing/afs191.
Morley JE. Pharmacologic options for the treatment of sarcopenia. Calcif Tissue Int 2015. http://dx.doi.org/10.1007/s00223-015-0022-5.
Montero-Fernandez N, Serra-Rexach JA. Role of exercise on sarcopenia in the elderly. Eur J Phys Rehabil Med 2013;49(1):131-43.
Freiberger E, Sieber C, Pfeifer K. Physical activity, exercise, and sarcopenia - future challenges. Wien Med Wochenschr 2011;161(17-18):416-25. http://dx.doi.org/10.1007/s10354-011-0001-z.
Laviano A, Gori C, Rianda S. Sarcopenia and nutrition. Adv Food Nutr Res 2014;71:101-36. http://dx.doi.org/10.1016/B978-0-12-800270-4.00003-1.
Malafarina V, Uriz-Otano F, Iniesta R, Gil-Guerrero L. Effectiveness of nutritional supplementation on muscle mass in treatment of sarcopenia in old age: a systematic review. J Am Med Dir Assoc 2013;14(1):10-7. http://dx.doi.org/10.1016/j.jamda.2012.08.001.
Bruyere O, Cavalier E, Souberbielle JC, Bischoff-Ferrari HA, Beaudart C, Buckinx F, et al. Effects of vitamin D in the elderly population: current status and perspectives. Arch Public Health 2014;72(1):32. http://dx.doi.org/10.1186/2049-3258-72-32.
Beaudart C, Buckinx F, Rabenda V, Gillain S, Cavalier E, Slomian J, et al. The effects of vitamin D on skeletal muscle strength, muscle mass, and muscle power: a systematic review and meta-analysis of randomized controlled trials. J Clin Endocrinol Metab 2014;99(11):4336-45. http://dx.doi.org/10.1210/jc.2014-1742.
Beaudart C, Rizzoli R, Bruyere O, Reginster JY, Biver E. Sarcopenia: burden and challenges for public health. Arch Public Health 2014;72(1):45. http://dx.doi.org/10.1186/2049-3258-72-45.